CLASS II Device recall · Reported 3 Aug 2016 · FDA Enforcement Report

Syva¿ EMIT¿ 2000 Theophylline recalled

Siemens Healthcare Diagnostics is recalling Syva¿ EMIT¿ 2000 Theophylline, distributed in 24 states. The recall was initiated on 17 Jun 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSyva¿ EMIT¿ 2000 Theophylline - Catalog # 4P019UL /SMN#10445324 Syva¿ EMIT¿ 2000 Theophylline - kit lot G3
Quantity recalled1,004 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2298-2016
FDA event ID
74524
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class II
Status
Terminated
Recall initiated
17 Jun 2016
FDA classified
28 Jul 2016
Reported
3 Aug 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

17 Jun 2016Recall initiated by company
28 Jul 2016Classified by FDA+41 days
3 Aug 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Siemens Healthcare Diagnostics has confirmed the Syva¿ EMIT¿ 2000 Theophylline reagent lot G3, when run on a Beckman AU Clinical Chemistry System, and the ADVIA¿ Chemistry Theophylline_2 (THEO_2) reagent lot 334018, may exhibit increased imprecision for commercially available Bio-Rad Liquichek TDM Quality Control Levels and patient samples.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Syva¿ EMIT¿ 2000 Theophylline - Catalog # 4P019UL /SMN#10445324 is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of theophylline in human serum or plasma.

Where it was distributed

Distributed to: CA, CT, DE, FL, GA, IA, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NM, NY, OH, OK, PA, TN, VA, WA

CaliforniaConnecticutDelawareFloridaGeorgiaIowaIndianaKansasKentuckyLouisianaMassachusettsMarylandMichiganMissouriNorth CarolinaNew JerseyNew MexicoNew YorkOhioOklahoma

Questions about this recall

Why was it recalled?

Siemens Healthcare Diagnostics has confirmed the Syva¿ EMIT¿ 2000 Theophylline reagent lot G3, when run on a Beckman AU Clinical Chemistry System, and the ADVIA¿ Chemistry Theophylline_2 (THEO_2) reagent lot 334018, may exhibit increased imprecision for commercially available Bio-Rad Liquichek TDM Quality Control Levels and patient samples.

Which lots are affected?

Syva¿ EMIT¿ 2000 Theophylline - Catalog # 4P019UL /SMN#10445324 Syva¿ EMIT¿ 2000 Theophylline - kit lot G3

Where was it sold?

Distributed to: CA, CT, DE, FL, GA, IA, IN, KS, KY, LA, MA, MD, MI, MO, NC, NJ, NM, NY, OH, OK, PA, TN, VA, WA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 74524

This product is part of a recall event; the main page for the event is Advia¿ Chemistry (Syva Onboard) Theophylline_2 recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIAdvia¿ Chemistry (Syva Onboard) Theophylline_2 recalledSiemens Healthcare DiagnosticsOther24 states

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656